Investors showed their approval of Cardinal Health Inc.'s (NYSE:CAH) $1.3 billion acquisition of drug distributor Kinray Inc., bidding up Cardinal's shares to their largest daily gain in a year and a half on Thursday.
First quarter profits for medical products and pharmaceuticals supplier Cardinal Health Inc. (NYSE:CAH) beat analysts expectations, though sales slipped slightly.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Medical product distributor Cardinal Health Inc. reported a 29 percent decline in third-quarter earnings, but the company still beat analysts’ expectations and raised its outlook for the full year. Earnings fell in part because last year’s results included CareFusion Corp., which Cardinal has since spun off. Excluding San Diego-based CareFusion, earnings grew about 5 percent […]
Cardinal Health CEO George Barrett thinks that he's ready to bring strong returns to the low-margin business left after the CareFusion spinoff that finalizes by the end of Monday.
Cardinal Health on Wednesday elected as planned its new chief executive officer, George Barrett, who has lead the Healthcare Supply Chain Services segment since January 2008.